[BRIEFING.COM] The S&P 500 (+0.2%) and DJIA (+0.3%) continue to hold modest gains, while a mostly lower showing from the "Magnificent Seven" keeps the Nasdaq Composite near its flat line.
The health care sector (+0.8%) continues to lead, supported by strong post-earnings gains in Labcorp Holdings Inc. (LH 365.48, +34.32, +10.36%) and GE HealthCare (GEHC 76.70, +5.59, +7.87%). Strength is relatively broad within the sector, with eleven components reaching fresh 52-week highs and the iShares Biotechnology ETF (IBB) advancing 2.0%. The outperformance comes despite continued weakness in Boston Scientific (BSX 42.20, -2.86, -6.36%), which has fallen to a four-year low after issuing below-consensus guidance despite beating Q3 expectations.